Halberd Corp (PK) (HALB) 뉴스

The s/p and volume say all that needs to be said.

"studies have been stellar" & "number of promising medicinal products"
You're misinterpreting the PR's don't feel bad most here are in the same boat.

You know what can't misinterpret, the financial statements.
No employees, no products, just a stinky pinky that Hartman has diluted into a reverse split, again...

You are more than welcome to block my post, as I will be posting anywhere that I choose to.
Good Luck to You

As always you have nothing to offer here. So, please don't bother stopping by, OK.

That's good. Do you care to divulge what was said in your email?
Things tend to drag on and on with no timely information, especially when a company has dealings with the government.

I must have missed something, since I just stop by from time to time, to see what's up?
Why the two listings for Hartless? ( Halberd Corporation ) ( Halberd Cancer Therapeutics LTD. )

Yes that's why they are here. I'm with you. I even received an email response from him. I'm not going anywhere that's for sure. :)

If you have any smarts you're loading up here between .0025 and .0031. All the studies so far have been stellar. I wouldn't bet against this company that has a number of promising medicinal products that actually help people. Game playing bashers probably know this and are buying in cheaper, that's all.

Charging Paddles, everyone stand back.
The patient is not responding? 😳

10 person study yielded great results. Now onto a 100 person study. :)

When the bashers make a LOT more sense than the blind pumpers, then 99.999999% of the time, the stock is a dead scam, growing in mold and death-residue.

GLTY

Let's hope with Trump back running the show that corrupt bureaucratic-boondoggles, such as the Federal Death Agency (FDA) and the Covid Death Center (CDC), are gutted back to some degree of sanity, and that innovative companies, such as Halberd with real medical products that actually help people, are allowed to move forward and flourish.

Halberd has a number products in the pipe-line that address critical medical issues and actually work to Make American-people Healthy Again.

Getting ready for another PR?

.0032 dumbass

The typical "dumper", OTCN hasn't even been in play. So it's this low because nobody wants it.
Perhaps paying .32 was too much. Might have to buy some lower, in order to squeeze out another win. SMH

$1100 in volume LMAO

Back at you

No it wasn't. But it's hard to tell that after the post prior to mine ended up missing. (As you can see, mine was temporarily missing also.
You can believe that you would have gotten a chuckle, had the "context" not gone away.

Hope all is well with you & yours.

Pretty sure this was meant for someone else.
I know you flip the POS better than most...
HALB ready for liftoff, just waiting on news.LMFAO

Total number of shareholders of record: 88

Convertible Judgments Payable and Contingent Liabilities:
As of July 31, 2024, there was a balance outstanding of $ 104,525 on this judgment that could be converted into approximately
298,642,911 shares of the Company’s common stock at a rate of approximately $0.00035 per share

Common Stock Warrants:
Warrants to purchase a total of 584,000,000 shares of common stock at a weighted average strike price of $0.01 were outstanding as of
July 31, 2024.

882,642,911 shares pending issuance and we all understand there are 800,000,000 authorized shares and 635,874,842 issued...

What does that mean for the 88 bagholders of HALB...

"answers" are "solutions" SMFH

Cheap enough, just don't make us sit on them too long.
But will take some 20's.

Exactly. :)

These bashing-losers on this board have all the "answers" but have ZERO solutions. Don't listen to their blathering-lunacy, that's all.

You should listen to others and "smarten up". lol You know what is much smarter than flipping from lows to highs?
It's putting your money in a ticker that shows that it can't hold any high ground for long and letting your money sit dead for months or even years.
Not to mention, that when & if you ever get to cash in, the opportunity cost have eaten away at your profits.
Uh? Wait a minute.....that doesn't sound right? Hmmmm? 🤔
(Folks are often oblivious to Opportunity Costs.)

You bashers need to smarten up and realize that this small bio-tech company is struggling to get new products into the market, which takes much time and effort. Added to that is the fact that this company has to deal with bureaucratic red tape from such big-government-agencies as the FDA and DOD, which even takes more time and effort. In addition, to get through FDA studies and bureaucratic-hoops takes several years.

This means that all systems are go to move forward with expanded studies, which looks good for new funding from gov'mnt and private sources.

Testing testing testing. It's how it works to become legit. :)

What exaclty does this mean for HALB?

Paragraph 2 Translation: Getting ready for more dilution.
JMO

More great news just released from Halberd:

JACKSON CENTER, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation. The results of that study can be found here. Based on the encouraging results of that initial pilot study, upgrades and enhancements to the data collection methodology, data analysis, hardware, software performance and reporting improvements have been incorporated into future studies. The next phase to be conducted on the patent-pending medicines/procedures is a 100-person study which will be conducted in sub-groups as volunteers are identified and qualified. The initial sub-group of 10 volunteers of this 100-person study have been selected. Results from this sub-group should be available around mid-January.

We are awaiting government and pending private investment funding to accelerate the 100-person study currently underway.

https://finance.yahoo.com/news/halberd-watchdawg-ptsd-treatment-130000055.html

HALB:

Shocking 😆

I have--Heard anything more about that $2 million grant from ESC? It's been going into Spooz (SPZI). Randall's involved behind the curtain. A new front man installed Dec 8th. A/S completely maxed out yet new management claims they own ZERO shares (except the Super Vote). Their "YUGGE NEWS" always followed by a drop in share price. ESC= tax evasion and money laundering IMO

The ultimate scam continues.

Uh huh, suuuure.

This is one sucky Annual. Revenue Down, shares Up and soon, so will the AS's. (Be up)
And don't even get me started on those Judgements + Warrants.
Without a R/S, the PPS is going to find a home in the trips. Nobody is buying their shares now, wait until they are forced to step up the selling.
🤪

https://www.otcmarkets.com/stock/HALB/disclosure

$900 in daily volume
HALB=POS

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Press Release | 10/01/2024
JACKSON CENTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veterans participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wrist monitor and used a mobile phone to upload vital sign data to the FDA-cleared Athena Device Management Suite (ADMS). Participant data was analyzed pre- and post-therapy. The study revealed consistent positive impact of the treatment with data indicating improved overall health.

During the study, various indicators of wellbeing were monitored in each participant via wearable technology developed by AthenaGTX, including, heart rate, blood oxygen level, respiration rate and skin temperature. Participants received troubleshooting support and participated in weekly Zoom calls with a physician to discuss system issues, problems, and anecdotal evidence. The program's details, objectives, and market summary were outlined in a prior press releases here and here.

Dr. Mark Darrah, CEO of Athena GTX, stated, “The results of this Pilot Study are very encouraging. We met all of our objectives set for this effort, helped the participants with improved health, and discovered ways we can improve the treatment methodology going forward. The proprietary LDX/CBN combination and specialized yoga/meditation positively impacted health and wellness, and the data acquisition system effectively supported participants. We will use what we learned plus feedback from participants to improve the treatment protocol as we proceed to a 100-patient Phase 1 clinical trial.”

Dr. Darrah continued, “As we enter the next programmed step, we wanted to remind any interested parties to consider enrolling in or supporting Phase 1 trials. This is an open invitation to witness first-hand the value and ease of the therapy and its impact.”

William A. Hartman, President and CEO of Halberd Corporation, added, “The results thus far indicate the treatment methodology is having very promising results in the long-term care and treatment of patients suffering from PTSD and associated physical health issues. We remain hopeful that this will result in a widely accepted standard of care.”

Note: The full Athena GTX WatchDawg press release can be accessed via this link.

To get the latest on Halberd’s exciting developments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/).

For more information please contact:

William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
Twitter: @HalberdC
0Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Press Release | 10/01/2024
JACKSON CENTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veterans participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wrist monitor and used a mobile phone to upload vital sign data to the FDA-cleared Athena Device Management Suite (ADMS). Participant data was analyzed pre- and post-therapy. The study revealed consistent positive impact of the treatment with data indicating improved overall health.

During the study, various indicators of wellbeing were monitored in each participant via wearable technology developed by AthenaGTX, including, heart rate, blood oxygen level, respiration rate and skin temperature. Participants received troubleshooting support and participated in weekly Zoom calls with a physician to discuss system issues, problems, and anecdotal evidence. The program's details, objectives, and market summary were outlined in a prior press releases here and here.

Dr. Mark Darrah, CEO of Athena GTX, stated, “The results of this Pilot Study are very encouraging. We met all of our objectives set for this effort, helped the participants with improved health, and discovered ways we can improve the treatment methodology going forward. The proprietary LDX/CBN combination and specialized yoga/meditation positively impacted health and wellness, and the data acquisition system effectively supported participants. We will use what we learned plus feedback from participants to improve the treatment protocol as we proceed to a 100-patient Phase 1 clinical trial.”

Dr. Darrah continued, “As we enter the next programmed step, we wanted to remind any interested parties to consider enrolling in or supporting Phase 1 trials. This is an open invitation to witness first-hand the value and ease of the therapy and its impact.”

William A. Hartman, President and CEO of Halberd Corporation, added, “The results thus far indicate the treatment methodology is having very promising results in the long-term care and treatment of patients suffering from PTSD and associated physical health issues. We remain hopeful that this will result in a widely accepted standard of care.”

Note: The full Athena GTX WatchDawg press release can be accessed via this link.

To get the latest on Halberd’s exciting developments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/).

For more information please contact:

William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
Twitter: @HalberdC

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD

JACKSON CENTER, Pa., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB), in coordination with Athena Telemedicine Partners (ATP) and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with the Halberd/Athena teams and to fund key advanced research, including the pending FDA IND study utilizing Halberd’s LDX technology and Athena Corporation’s WatchDawg™ monitoring technology.

Defense Atomics Corporation agreed to use its proprietary CRISPR/Nanotechnology Stem Cell treatment for PTSD/TBI in a minimum of 10 paid veterans in a government pilot study of this cutting-edge protocol. Based on Defense Atomics’ success using CRISPR methodology with overseas patients, this study is intended to substantiate the benefits of this technology in conjunction with Halberd/Athena’s LDX PTSD and TBI/Brain Injury protocol.

https://finance.yahoo.com/news/halberd-partnership-secures-contract-defense-120000500.html

Ohhh, a tenderfoot.

Resorting to name calling. Wow tough guy. :) Here's your previous quote> "Sure. Have not owned a share of this for over 6 years now." So get the f out then. :)

Nice try?? Doofus. The HALB PR is still promoting them as an active element of their program. Take a look at the years and the pps. This is cooked hogwash. I wish your your sake it wasn't, but it is.

Defense Atomics Corp has been out for a long time. Old news but nice try. We ALL know Athena GTX is paving the way. :) .

Seems the naysayers had it right all along. Fools and their past money, parted a LONG time ago.

Especially in light of the fact that Defense Atomics Corp does not exist as a company anymore. Has not for quite a while.

" anecdotal evidence " That's why the PR fell flat. Sad, but true.

Good results from a problem that reaches worldwide. I'm already to see it hit a buck or get bought out. :)

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System

Jackson Center, PA October 1, 2024 – Halberd Corporation (OTC-PINK: "HALB”) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veteran participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wrist monitor and used a mobile phone to upload vital sign data to the FDA-cleared Athena Device Management Suite (ADMS). Participant data was analyzed pre- and post-therapy. The study revealed consistent positive impact of the treatment with data indicating improved overall health.

During the study, various indicators of wellbeing were monitored in each participant via wearable technology developed by AthenaGTX, including, heart rate, blood oxygen level, respiration rate and skin temperature. Participants received troubleshooting support and participated in weekly Zoom calls with a physician to discuss system issues, problems, and anecdotal evidence. The program's details, objectives, and market summary were outlined in a prior press releases here and here.

Dr. Mark Darrah, CEO of Athena GTX, stated, “The results of this Pilot Study are very encouraging. We met all of our objectives set for this effort, helped the participants with improved health, and discovered ways we can improve the treatment methodology going forward. The proprietary LDX/CBN combination and specialized yoga/meditation positively impacted health and wellness, and the data acquisition system effectively supported participants. We will use what we learned plus feedback from participants to improve the treatment protocol as we proceed to a 100-patient Phase 1 clinical trial.”

Dr. Darrah continued, “As we enter the next programmed step, we wanted to remind any interested parties to consider enrolling in or supporting Phase 1 trials. This is an open invitation to witness first-hand the value and ease of the therapy and its impact.

William A. Hartman, President and CEO of Halberd Corporation, added, “The results thus far indicate the treatment methodology is having very promising results in the long-term care and treatment of patients suffering from PTSD and associated physical health issues. We remain hopeful that this will result in a widely accepted standard of care.”

mdiConsultants guiding the FDA clearance path

LDX will be on the market soon

Another 100 patient test will follow

New PR with test resulta